Stay updated on BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision tag was updated from `v3.5.2` to `v3.5.3`, indicating a minor backend update to the page record.
    Difference
    0.0%
    Check dated 2026-04-30T17:26:36.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:30:26.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    A new revision label v3.5.0 was added and the previous label v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:41:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:45:00.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The update is a minor version change (Revision: v3.4.2) and removal of a general government funding status notice; there are no changes to study content, eligibility criteria, primary or secondary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:34:17.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T01:38:09.000Z thumbnail image

Stay in the know with updates to BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.